1-44129981-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000372299.4(KLF17):āc.710A>Gā(p.Asp237Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,613,748 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000372299.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KLF17 | NM_173484.4 | c.710A>G | p.Asp237Gly | missense_variant | 2/4 | ENST00000372299.4 | NP_775755.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KLF17 | ENST00000372299.4 | c.710A>G | p.Asp237Gly | missense_variant | 2/4 | 1 | NM_173484.4 | ENSP00000361373.3 | ||
KLF17 | ENST00000476802.1 | n.290-53A>G | intron_variant | 3 | ENSP00000489364.1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 151736Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000437 AC: 11AN: 251474Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135910
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461894Hom.: 0 Cov.: 36 AF XY: 0.0000220 AC XY: 16AN XY: 727248
GnomAD4 genome AF: 0.000138 AC: 21AN: 151854Hom.: 0 Cov.: 32 AF XY: 0.000162 AC XY: 12AN XY: 74220
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2024 | The c.710A>G (p.D237G) alteration is located in exon 2 (coding exon 2) of the KLF17 gene. This alteration results from a A to G substitution at nucleotide position 710, causing the aspartic acid (D) at amino acid position 237 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at